29 September 2018 in International Journal on Advanced Science, Engineering and Information Technology
Currently, the long-term consumption of aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) as anti-inflammatory medicines and pain relievers, have been reported to cause various side effects. Thus, natural compounds of several plant species including Aquilaria malaccensis have been explored as an alternative therapeutic source for inflammation treatment with regard to their safety and efficacy. Despite the accelerating rate on the research of agarwood leaf, the scientific evidences to elucidate the proclaimed pharmacological activities particularly anti-inflammatory activity are still limited. Therefore, it is the interest of this study to investigate the biological activity relating to the anti-inflammatory activity of A. malaccensis leaf extracted using Soxhlet and Supercritical Fluid Extraction (SFE) methods. Results showed that A. malaccensis leaf ethanolic soxhlet extract (ALEXB) gave higher yield (mg/g) of 98.33 ± 4.11 (9.83% wt/wt) as compared to soxhlet extract using hexane (ALEXA); 24.04 ± 5.27 (2.40% wt/wt) after 6 hours of extraction. Meanwhile, the supercritical fluid extract (SFEX) gave a relatively low yield of 12.57 ± 0.61 (1.26% wt/wt). The GCMS analysis revealed that 25, 30 and 16 compounds were detected in ALEXA, ALEXB and SFEX respectively with phytol as the major compound in the soxhlet extracts and n-hexadecanoic as a major compound in SFEX. Subsequently, in-vitro study showed that the extracts demonstrated inhibition of protein (albumin) denaturation in a concentration-dependent manner throughout a concentration range of 400-16000 µg/ml tested. Exclusively, the GCMS of leaf SFEX showed a peak of 1H-Cycloprop[e]azulene, decahydro-1,1,7-trimethyl-4-methylene (0.4205%), a tricyclic sesquiterpene that was testified to have potential analgesic and anti-inflammatory activity. Further research is warranted to explore the anti-inflammatory activities of A. malaccensis leaf extracts and their mechanism of action as an alternative halal ingredient for nutraceuticals and pharmaceuticals.
10 February 2020 in Food Research
Bioactive compounds from plants have been shown to possess therapeutic values which are being used as medicine as well as ingredients for functional foods and nutraceuticals. While qualitative and quantitative studies on the bioactive compounds of plant extract are important to establish their claimed therapeutic properties; less is focused on effects and interrelationship of process (extraction) conditions used to obtain the desired bioactive compounds. As such, this study intended to determine the effects of different parameters on the extraction of Aquilaria malaccensis leaf extract (ALEX) bioactive compounds. Metabolite profiling of bioactive compounds of ALEX samples was conducted using gas chromatography-mass spectrometry (GCMS) with subsequent multivariate statistical analysis through principal component analysis (PCA) with the aid of MATLAB software. The GCMS analysis detected diverse potential bioactive compounds in ALEX samples with hydrocarbon, terpenes and esters being the primary groups. n-hexadecanoic acid and hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester were found to be present in most of the ALEX samples. PCA showed that same Soxhlet extraction parameters were able to cluster the samples together and separate samples extracted with different extraction parameters based on the relative abundance of the particular compounds. In conclusion, it is notable that the samples were significantly separated based on Soxhlet extraction time as compared to the solid to solvent ratio and the suggested best Soxhlet extraction parameters were 18 hrs and 1:70 solid to solvent ratio. The findings from this study will facilitate the extraction and purification of the desired bioactive compounds from agarwood leaf that can be further used in development of functional foods and nutraceuticals.
29 September 2018 in International Journal on Advanced Science, Engineering and Information Technology
Breast cancer continues to remain as the leading cause of cancer mortality among women worldwide. Agents for prevention and cure for breast cancer are contiuously being researched. İn particular, agarwood essential oil from resin infiltrated heartwood has been reported to have substantial evidences of medicinal benefits. Nevertheless, there is very limited report on agarwood leaf essential oil (ALEO). Hence, this present study was conducted to evaluate the physicochemical properties, chemical constituents and anticancer activity of ALEO. ALEO was observed to be of pale-yellow colour with sweet smell. Other physicochemical properties include refractive index of 1.44, specific gravity of 0.886, saponification value of 131.88 mg KOH/g, acid value of 2.80 mg KOH/g and iodine value of 105.07 gI2/100g. The profiling of chemical constituents using gas chromatography-mass spectrometry (GCMS) revealed 19 compounds. Hexadecanoic acid was the major compound (64.41%). The biomarkers of agarwood; azulene (0.619%) and guaiol (0.2997%) were also detected. ALEO was tested for anticancer activity against MCF-7 cancer cells using WST-8 assay. ALEO showed the IC50 value of 31% (v/v) against MCF-7 cells after 36 hours of treatment. In conclusion, this study provides information on ALEO physicochemical properties and chemical constituents that can be used as benchmark for quality assurance as well as proof that ALEO holds a potential as anticancer agent.
5 January 2026 in medRxiv
ABAnuradha U K H Bambarandhage
Anuradha U K H Bambarandhage
+4
Introduction: Breast Cancer (BC) remains a significant clinical challenge, and despite well-established screening strategies, new biomarkers could improve BC detection, treatment and management. Urine represents a headily accessible liquid biopsy for diagnosis and extracellular vesicle (EV) transfer of oncogenic proteins, RNAs, and metabolites that promote tumor growth, invasion, metastasis, and immune evasion. Aims: To compare the whole urine and urinary EV metabolomes and identify BC specific metabolite changes. Methodology: Urine samples were collected from four participant groups: breast cancer (BC) patients (n = 42), individuals with breast benign disease (BBD; n = 3), symptom controls (SC; n = 4), and healthy controls (HC; n = 6). EVs were isolated using differential centrifugation, ultrafiltration, and size-exclusion chromatography (SEC), and their morphology was confirmed by transmission electron microscopy (TEM). Metabolites from whole urine and from EVs derived from the same samples were extracted using methanol–water (70:30, v/v) and analyzed by direct-infusion mass spectrometry (DI-MS) in both positive and negative ESI modes. Metabolic features were processed with BinneR and annotated using the HMDB and KEGG databases. Integrated multi-omics analysis of whole-urine and EV-associated metabolomes was performed using the DIABLO framework within the MixOmics package in R platform. Results: DI-MS profiling detected a broad spectrum of metabolites in both whole–urine and EV–derived fractions. Multivariate analyses revealed a clear separation of breast cancer (BC) patients from healthy controls and non–cancer groups in both matrices. Whole EV metabolites with area under the curves (AUC) of > 0.7 included glyceryl phosphoryl derivatives, N-eicosapentaenoyl species, sphinganine-1-phosphate and tetracosahexaenoic acid. EV–enriched metabolites included carnitine, histidine and adenosine monophosphate. DIABLO–based integrative analysis suggested that urinary and EV metabolomes were broadly similar with the discrete putative metabolite biomarkers representing minor, but specific changes with BC. Conclusions: The whole urine and EV metabolomes suggested a small number of metabolite changes that were specific to BC. This could indicate that the urinary EVs describe distinctive aspects of the breast carcinogenic process.